Literature DB >> 9739023

Various regions within the alpha-helical domain of the COL1A1 gene are fused to the second exon of the PDGFB gene in dermatofibrosarcomas and giant-cell fibroblastomas.

K P O'Brien1, E Seroussi, P Dal Cin, R Sciot, N Mandahl, J A Fletcher, C Turc-Carel, J P Dumanski.   

Abstract

Dermatofibrosarcoma protuberans (DFSP) and its juvenile form, giant-cell fibroblastoma (GCF), are uncommon infiltrative tumors of the dermis, which present unique cytogenetic features, such as the reciprocal translocation t(17;22) or, more commonly, supernumerary ring chromosomes containing sequences from chromosomes 17 and 22. We have recently shown that these aberrations are cytogenetic manifestations of gene fusions between the platelet-derived growth factor B-chain gene (PDGFB), the cellular equivalent of the v-sis oncogene, and the collagen type 1 alpha 1 gene (COL1A1), the major protein constituent of the extracellular matrix in connective tissue of skin. We now report characterization of COL1A1/PDGFB chimeric genes at the RNA and DNA sequence levels in a series of DFSPs and GCFs. All 16 tumors studied contained the COL1A1/PDGFB gene. The location of breakpoints within COL1A1 varied greatly, but was always limited to the region encoding the alpha-helical domain. The PDGFB segment of the chimeric transcript always starts with exon 2, placing PDGFB under the control of the COL1A1 promoter and removing all known elements negatively controlling PDGFB transcription and translation. Production of these aberrant transcripts in fibroblasts, the suspected cell of origin of DFSP/GCF, likely causes autocrine stimulation and cell proliferation. No specific function has yet been assigned to exon 2 of PDGFB, and this exon does not encode for the mature growth factor. Its retention in all chimeric COL1A1/PDGFB genes suggests that it is important for the normal processing of the PDGFB polypeptide.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9739023

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  24 in total

1.  COL1A1-PDGFB fusion transcripts in fibrosarcomatous areas of six dermatofibrosarcomas protuberans.

Authors:  J Wang; Y Morimitsu; S Okamoto; M Hisaoka; T Ishida; W Sheng; H Hashimoto
Journal:  J Mol Diagn       Date:  2000-02       Impact factor: 5.568

2.  Transformed dermatofibrosarcoma protuberans: real time polymerase chain reaction detection of COL1A1-PDGFB fusion transcripts in sarcomatous areas.

Authors:  Zoltan Szollosi; Beata Scholtz; Kristof Egervari; Zoltan Nemes
Journal:  J Clin Pathol       Date:  2006-05-26       Impact factor: 3.411

3.  Fusion of the COL1A1 and FYN Genes in Epithelioid Osteoblastoma.

Authors:  Ioannis Panagopoulos; Ludmila Gorunova; Ingvild Lobmaier; Marius Lund-Iversen; Kristin Andersen; Arild Holth; Bodil Bjerkehagen; Sverre Heim
Journal:  Cancer Genomics Proteomics       Date:  2019 Sep-Oct       Impact factor: 4.069

4.  Dermatofibrosarcoma Protuberans-Like Tumor With COL1A1 Copy Number Gain in the Absence of t(17;22).

Authors:  Jad Saab; Ian M Rosenthal; Lu Wang; Klaus J Busam; Kishwer S Nehal; Mark A Dickson; Meera R Hameed; Travis J Hollmann
Journal:  Am J Dermatopathol       Date:  2017-04       Impact factor: 1.533

Review 5.  Genomic characteristics of soft tissue sarcomas.

Authors:  Fredrik Mertens; Ioannis Panagopoulos; Nils Mandahl
Journal:  Virchows Arch       Date:  2009-02-03       Impact factor: 4.064

6.  Activation of the GLI oncogene through fusion with the beta-actin gene (ACTB) in a group of distinctive pericytic neoplasms: pericytoma with t(7;12).

Authors:  Anna Dahlén; Christopher D M Fletcher; Fredrik Mertens; Jonathan A Fletcher; Antonio R Perez-Atayde; M John Hicks; Maria Debiec-Rychter; Raf Sciot; Johan Wejde; Rikard Wedin; Nils Mandahl; Ioannis Panagopoulos
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

7.  Sunitinib for patients with locally advanced or distantly metastatic dermatofibrosarcoma protuberans but resistant to imatinib.

Authors:  Yan Fu; Huanrong Kang; Hui Zhao; Jia Hu; Huanhuan Zhang; Xiaosong Li; Nan Du; Yitao Huang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 8.  Molecular genetics of pediatric soft tissue tumors: clinical application.

Authors:  Chung-Che Chang; Vinod B Shidham
Journal:  J Mol Diagn       Date:  2003-08       Impact factor: 5.568

9.  Imatinib in the treatment of dermatofibrosarcoma protuberans.

Authors:  Stefanos V Labropoulos; Evangelia D Razis
Journal:  Biologics       Date:  2007-12

Review 10.  Molecular pathology of sarcomas: concepts and clinical implications.

Authors:  Judith V M G Bovée; Pancras C W Hogendoorn
Journal:  Virchows Arch       Date:  2009-09-29       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.